rdf:type |
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0008976,
umls-concept:C0087111,
umls-concept:C0205265,
umls-concept:C0242708,
umls-concept:C0332281,
umls-concept:C0580822,
umls-concept:C0871261,
umls-concept:C1521761,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594,
umls-concept:C1555582,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1709323,
umls-concept:C2911692
|
pubmed:issue |
5
|
pubmed:dateCreated |
2004-4-22
|
pubmed:abstractText |
To determine what baseline factors might be associated with response to an initial mild treatment regimen in patients with early rheumatoid arthritis (RA).
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1462-0324
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
619-25
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:14983105-Adult,
pubmed-meshheading:14983105-Aged,
pubmed-meshheading:14983105-Algorithms,
pubmed-meshheading:14983105-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:14983105-Antirheumatic Agents,
pubmed-meshheading:14983105-Arthritis, Rheumatoid,
pubmed-meshheading:14983105-Drug Therapy, Combination,
pubmed-meshheading:14983105-Female,
pubmed-meshheading:14983105-Follow-Up Studies,
pubmed-meshheading:14983105-Humans,
pubmed-meshheading:14983105-Hydroxychloroquine,
pubmed-meshheading:14983105-Male,
pubmed-meshheading:14983105-Methotrexate,
pubmed-meshheading:14983105-Middle Aged,
pubmed-meshheading:14983105-Prognosis,
pubmed-meshheading:14983105-Severity of Illness Index,
pubmed-meshheading:14983105-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
|
pubmed:affiliation |
Division of Rheumatology, Mayo Clinic and Mayo Graduate School of Medicine, Rochester, MN 55905, USA. matteson.eric@Mayo.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|